542771 — Novateor Research Laboratories Cashflow Statement
0.000.00%
- IN₹348.00m
- IN₹353.51m
- IN₹27.77m
Annual cashflow statement for Novateor Research Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | R2022 March 31st | R2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | Interim Report | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 0.173 | -2.28 | 0.395 | 0.463 | 1.13 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 0.297 | 0.342 | -4.73 | -4.56 | -4.04 |
Other Non-Cash Items | |||||
Changes in Working Capital | -4.09 | -12.2 | -6.22 | -6.48 | -8.1 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -2.66 | -13.2 | -9.7 | -9.76 | -9.37 |
Capital Expenditures | -0.916 | -15.1 | -3.56 | -7.36 | -6.96 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0 | 0 | 4.9 | 4.84 | 4.75 |
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.916 | -15.1 | 1.34 | -2.52 | -2.22 |
Financing Cash Flow Items | 1.42 | 1.42 | -0.192 | -0.257 | -0.712 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 3.22 | 3.49 | 5.8 | 11 | 13.4 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.351 | -24.8 | -2.56 | -1.3 | 1.77 |